Tri-Cities Tech Business Update
New R&D vice-president at IsoRay
William Cavanagh has joined Richland, Wash.-based IsoRay, Inc. as the company's vice-president of research and development. He has been involved in cancer treatment research and development for more than 20 years and most recently served as the chief scientific officer for Seattle, Wash.-based Sangretech Biomedical. IsoRay is the sole producer of the Cesium-131 brachytherapy seed, which is currently used in the treatment of prostate cancer and ocular melanoma among other cancerous conditions.
Contact Dwight Babcock at 520-240-4840.
